SUBSCRIBE
SUBSCRIBE

Ovid Therapeutics

NEWS
Drug Development
Three Profiles: When Big Pharma Execs Opt to Lead Biotech Startups
Pharmaceutical execs who leave their positions with big pharmaceutical companies, unless opting to retire for good, often move to leadership positions at other big companies. There are other choices.
May 7, 2018
 · 
5 min read
 · 
Mark Terry
Business
CEOs Of Decibel And Ovid Urge Peers To ‘Stand Up To Trump’
August 24, 2017
 · 
1 min read
3 Biotechs That Could be Taken Out This Quarter
Deals
It’s Official: Ovid CEO Just Filed for $86 Million IPO
April 12, 2017
 · 
2 min read
Japan's Konica Minolta Takes Out SoCal Diagnostics Firm Ambry Genetics in $1 Billion Deal
Business
Tiny Ovid Inks a Unique Rare Disease Deal With Drug Giant Takeda
January 18, 2017
 · 
2 min read
Business
Top 20 Life Science Startups to Watch in the U.S.
BioSpace is pleased to present its NextGen Bio “Class of 2016.” This list contains 20 life science companies that launched no earlier than 2013 and are headquartered in the United States.
January 26, 2016
 · 
15 min read
 · 
Mark Terry
What You Need to Know About Ovid
Business
What You Need to Know About Ovid
December 2, 2015
 · 
6 min read
Load More
AWARDS
  • NextGen Class of 2016
JOBS
IN THE PRESS
Business
Ovid Therapeutics Expands Its Scientific Leadership Team & Appoints Chief Strategy Officer
June 28, 2023
 · 
7 min read
Deals
Ovid Therapeutics Added to Russell 3000® Index
June 26, 2023
 · 
4 min read
Business
Ovid Therapeutics Reports First Quarter 2023 Financial Results and Corporate Updates
May 5, 2023
 · 
12 min read
Business
Ovid Therapeutics Announces Collaboration with Graviton Bioscience, Proven Developers of Selective ROCK2 Inhibitors
May 1, 2023
 · 
8 min read
Genetown
Long-term Safety & Efficacy Findings from Soticlestat Open Label Extension Study Presented by Takeda at American Academy of Neurology Annual Meeting
April 27, 2023
 · 
9 min read
Pharm Country
Ovid Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference
April 10, 2023
 · 
3 min read
Pharm Country
Ovid Therapeutics to Present at the 2nd Annual Needham Virtual Neuroscience Forum
March 9, 2023
 · 
3 min read
Drug Development
Studies Published in Cell Reports Medicine Validate the Potential of Direct KCC2 Activation in Resistant Seizures
March 8, 2023
 · 
8 min read
Pharm Country
Ovid Therapeutics to Present at the 43rd Annual Cowen Healthcare Conference
February 28, 2023
 · 
1 min read
Business
Ovid Therapeutics Expands Epilepsy Development Expertise with New Appointments
February 8, 2023
 · 
5 min read
Load More